R21TW012365
Project Grant
Overview
Grant Description
Evaluating smoking cessation and harm reduction approaches among people living with HIV/AIDS in South Africa.
Awardee
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 110% from $189,952 to $399,602.
New York University was awarded
Smoking Cessation & Harm Reduction in HIV/AIDS
Project Grant R21TW012365
worth $399,602
from Fogarty International Center in July 2022 with work to be completed primarily in New York United States.
The grant
has a duration of 2 years and
was awarded through assistance program 93.989 International Research and Research Training.
The Project Grant was awarded through grant opportunity HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional).
Status
(Complete)
Last Modified 7/5/23
Period of Performance
7/1/22
Start Date
6/30/24
End Date
Funding Split
$399.6K
Federal Obligation
$0.0
Non-Federal Obligation
$399.6K
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R21TW012365
Transaction History
Modifications to R21TW012365
Additional Detail
Award ID FAIN
R21TW012365
SAI Number
R21TW012365-537162877
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Funding Office
75NF00 NIH FOGARTY INTERNATIONAL CENTER
Awardee UEI
M5SZJ6VHUHN8
Awardee CAGE
3D476
Performance District
12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Representative
Jerrold Nadler
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
John E. Fogarty International Center, National Institutes of Health, Health and Human Services (075-0819) | Health research and training | Grants, subsidies, and contributions (41.0) | $399,602 | 100% |
Modified: 7/5/23